From July 1, 2022 to August 18, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 227,719 shares, representing 3.24% for KRW 3,718.7 million under the buyback announced on February 18, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,400 KRW | -0.15% | +6.94% | +19.43% |
1st Jan change | Capi. | |
---|---|---|
+19.43% | 66.38M | |
+16.44% | 122B | |
+18.94% | 114B | |
+19.62% | 25.71B | |
-25.37% | 19.02B | |
-20.21% | 15.83B | |
-20.20% | 15.32B | |
-47.37% | 14.88B | |
+59.91% | 14.82B | |
+4.35% | 14.1B |
- Stock Market
- Equities
- A049960 Stock
- News Cell Biotech Co., Ltd.
- Tranche Update on Cell Biotech Co., Ltd.'s Equity Buyback Plan announced on February 18, 2022.